Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of a Rapid Test for the Detection of Methylation Profiles (Methylscape) in Various Body Fluids as a Universal Biomarker for Cancer Detection and Monitoring

NCT07741435 is registered in ClinicalTrials.gov with Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo as lead sponsor.

NCT NCT07741435
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07741435 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of a Rapid Test for the Detection of Methylation Profiles (Methylscape) in Various Body Fluids as a Universal Biomarker for Cancer Detection and Monitoring
Lead sponsor
Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo
Phase
Observational
Overall status
Recruiting
Start date
June 5, 2025
Completion date
January 15, 2028
Enrollment
3,250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms, colorectal neoplasms, early detection of cancer, head and neck neoplasms, lung neoplasms, neoplasm recurrence, local, neoplasms, solid tumor, stomach neoplasms, urologic neoplasms, uterine cervical neoplasms